Gray matter nucleus hyperintensity after monthly triple-dose gadopentetate dimeglumine with long-term magnetic resonance imaging
JJ DeBevits IV, R Munbodh, D Bageac, R Wu… - Investigative …, 2020 - journals.lww.com
… DeBevits, John J. IV MD ∗ ; Munbodh, Reshma PhD † ; Bageac, Devin BS ∗ ; Wu, Rong PhD,
… John J. DeBevits and Reshma Munbodh contributed equally to this project and are to be …
… John J. DeBevits and Reshma Munbodh contributed equally to this project and are to be …
A comprehensive analysis of cerebellar volumes in the 22q11. 2 deletion syndrome
Background The presence of a 22q11.2 microdeletion (22q11.2 deletion syndrome [22q11DS])
ranks among the greatest known genetic risk factors for the development of psychotic …
ranks among the greatest known genetic risk factors for the development of psychotic …
[HTML][HTML] MRI demonstration of gadolinium deposition in bone after monthly triple-dose gadopentetate dimeglumine and correlation with frequency of …
D Bageac, JJ DeBevits, R Munbodh, J Kaplan, R Wu… - Clinical imaging, 2021 - Elsevier
Objectives We retrospectively analyzed data of the BECOME trial to investigate whether
serial administration of triple-dose (3-dose) gadopentetate dimeglumine would result in the …
serial administration of triple-dose (3-dose) gadopentetate dimeglumine would result in the …
Synthesizing Contrast-Enhanced MR Images from Noncontrast MR Images Using Deep Learning
…, FY Fang, M Achilleos, J DeBevits… - American Journal …, 2024 - Am Soc Neuroradiology
BACKGROUND AND PURPOSE: Recent developments in deep learning methods offer a
potential solution to the need for alternative imaging methods due to concerns about the …
potential solution to the need for alternative imaging methods due to concerns about the …
Structural MRI Ratios Fail to Distinguish Progressive Supranuclear Palsy From Parkinson Disease in Individual Patients
…, F Feltrin, B Shah, M Pinho, J DeBevits… - Neurology: Clinical …, 2023 - AAN Enterprises
Background and Objectives Parkinson disease (PD) and progressive supranuclear palsy (PSP)
are often difficult to differentiate in the clinic. The MR parkinsonism index (MRPI) has …
are often difficult to differentiate in the clinic. The MR parkinsonism index (MRPI) has …
Non-secretory Multiple Myeloma Associated with Diffuse Osteosclerotic Bone Lesions: A Case Report and Review of Cases since 1997
T Veeramachaneni, J DeBevits, LD Anderson, JM Jaso… - 2023 - researchsquare.com
Background: Multiple myeloma is the second most common hematologic malignancy typically
involving monoclonal immunoglobulin secretion by malignant plasma cells and lytic bone …
involving monoclonal immunoglobulin secretion by malignant plasma cells and lytic bone …
Gadolinium-induced Marrow Signal Changes with Metabolic Correlation: Are Cell Lines Directly Affected?
JJ DeBevits, D Bageac, L Wolansky, P Dicamillo, R Wu… - archive.ismrm.org
In the BECOME trial, subjects experienced progressively increased T1W signal changes in
deep grey matter nuclei. This retrospective analysis concluded these signal changes also …
deep grey matter nuclei. This retrospective analysis concluded these signal changes also …
Diffusion-weighted imaging discriminates progressive supranuclear palsy from PD, but not from the parkinson variant of multiple system atrophy
K Seppi, MFH Schocke, R Esterhammer, C Kremser… - Neurology, 2003 - AAN Enterprises
Background and objective: The parkinson variant of multiple system atrophy (MSA-P) and
progressive supranuclear palsy (PSP) present with atypical parkinsonism, which may be …
progressive supranuclear palsy (PSP) present with atypical parkinsonism, which may be …
Effect of anti-IFNβ antibodies on MRI lesions of MS patients in the BECOME study
AR Pachner, D Cadavid, L Wolansky, J Skurnick - Neurology, 2009 - AAN Enterprises
Background: Interferon beta (IFNβ) administered subcutaneously is immunogenic in some
patients with multiple sclerosis (MS) and leads to the development of neutralizing antibodies (…
patients with multiple sclerosis (MS) and leads to the development of neutralizing antibodies (…
Extent of signal hyperintensity on unenhanced T1-weighted brain MR images after more than 35 administrations of linear gadolinium-based contrast agents
Purpose To explore the extent of signal hyperintensity in the brain on unenhanced T1-weighted
magnetic resonance (MR) images with increasing gadolinium-based contrast agent (…
magnetic resonance (MR) images with increasing gadolinium-based contrast agent (…